Faculty Directory │ Academics │ GCSP

Faculty

Faculty Directory

Dae Yong KIM

Name: Dae Yong KIM, M.D., Ph.D.(adjunct professor)
Faculty Appointment (title, department): Professor, Department of Cancer Control and Population Health, NCC-GCSP
Area of Expertise: Radiation Oncology (Gastrointestinal Cancer)
E-mail: radiopia@ncc.re.kr

Work Experience: Specialist, Center for Proton Therapy, National Cancer Center (2003-Present)
Specialist, Department of Radiation Oncology, National Cancer Center (2012-Present)
Director, National Cancer Control Institute, National Cancer Center (2018-Present)
Adjunct, Center for Proton Therapy, National Cancer Center (2019-Present)
Adjunct Scientist, Division of Convergence Technology, Natinoal Cancer Center (2019-Present)
Educational Background: M.D Seoul National University College of Medicine (1981-1988)
M.S Seoul National University College of Medicine (1994-1996)
Ph.D Chungbuk National University College of Medicine (1999-2001)
Research Interests: Proton and radiation therapy for colorectal cancer, treatment method for recurrent colorectal cancer, and predictive factors of chemoradiotherapy before surgery in colorectal cancer.
Achievements (Total: 178 SCI: 120 SCI-E: 54 etc: 4 SSCI: 0 SCI+SCI-E+SSCI: 0): 2019 SCI Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma:SCIENTIFIC REPORTS. 9(1):11770~11770 (4.011)

2019 SCI-E Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer:CANCER RESEARCH AND TREATMENT. Online:Published (3.363)

2019 SCI-E Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma?:CANCERS. 11(2):E230~E230 (6.162)

2018 SCI Colorectal cancer susceptibility loci and influence on survival:genes chromosomes cancer. 57(12):630~637 (3.362)

2018 SCI Patterns of failure in rectal cancer with positive circumferential resection margin after surgery following preoperative chemoradiation: a propensity score matching analysis:The British journal of radiology. 91(1092):20180143~20180143 (1.814)

2018 SCI Feasibility of selective lateral node dissection based on magnetic resonance imaging in rectal cancer after preoperative chemoradiotherapy:Journal of Surgical Research. 232:227~233 (2.051)

2018 SCI-E Analysis of unexplained carcinoembryonic antigen elevation after curative treatment of locally advanced rectal cancer:International journal of clinical oncology. 23(5):924~929 (2.61)

2018 SCI-E Breast Conservation Therapy versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23:CANCER RESEARCH AND TREATMENT. 50(4):1316~1323 (3.23)

2018 기타 Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boostintensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer:Radiation Oncology Journal. 36(3):200~209 (0)

2018 SCI A Randomized Phase 2 Trial of Consolidation Chemotherapy After Preoperative Chemoradiation Therapy Versus Chemoradiation Therapy Alone for Locally Advanced Rectal Cancer: KCSG CO 14-03:International journal of radiation oncology, biology, physics. 101(4):889~899 (5.554)

2018 SCI-E Effectiveness and Safety of Simultaneous Integrated Boost-Proton Beam Therapy for Localized Pancreatic Cancer:Technology in cancer research & treatment. 17:1~9 (1.646)

2018 SCI-E Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings:PLoS One. 13(4):e0195815~e0195815 (2.766)

2017 SCI-E The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma.:Cancer research and treatment. 50(3):1039~1050 (3.772)

2017 SCI-E Redefining the Positive Circumferential Resection Margin by Incorporating Preoperative Chemoradiotherapy Treatment Response in Locally Advanced Rectal Cancer, a Multicenter Validation Study:Cancer Research and Treatment. 50(2):506~517 (3.772)

2017 SCI-E Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea.:Cancer Research and Treatment. 50(2):335~344 (3.772)

2017 SCI Tolerance design of patient-specific range QA using the DMAIC framework in proton therapy:Medical Physics. 45(2):520~528 (2.617)

2017 SCI Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer: A Phase II Open Label Prospective Randomized Controlled Trial:Annals of Surgery. 267(2):243~251 (8.98)

2017 SCI Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance:European Radiology. 28(2):496~505 (3.967)

2017 SCI-E Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma:Oncotarget. 9(3):4034~4043 (5.168)

2017 SCI-E Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer:Surgical Oncology-Oxford. 26(4):453~459 (3.304)

2017 SCI-E A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis:Radiation Oncology. 12(1):62~62 (2.568)

2016 SCI Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis:Radiotherapy and Oncology. 122(1):122~129 (4.817)

2016 SCI Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases:American Journal of Clinical Oncology. 39(6):623~629 (2.977)

2016 SCI Adjuvant radiotherapy for the treatment of stage IV rectal cancer after curative resection A propensity score-matched analysis and meta-analysis:Medicine. 95(47):e4925~e4925 (2.133)

2016 SCI-E Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis After Resection of Brain Metastases in Breast Cancer Patients:Cancer Research and Treatment. Online:Published (4.245)

2016 SCI-E A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy:Radiation Oncology. 11(1):140~140 (2.466)

2016 SCI Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas:Strahlenther Onkol. 192(9):649~657 (2.898)

2016 SCI Is lateral pelvic node dissection necessary after preoperative chemoradiotherapy for rectal cancer patients with initially suspected lateral pelvic node?:Surgery. 160(2):366~376 (3.309)

2016 SCI Two-dimensional in vivo rectal dosimetry using an endorectal balloon with unfoldable radiochromic film during prostate cancer radiotherapy:Radiotherapy and oncology. 120(2):327~332 (4.817)

2016 SCI Timely tumor response analysis after preoperative chemoradiotherapy and curative surgery in locally advanced rectal cancer: A multi-institutional study for optimal surgical timing in rectal cancer:Radiotherapy and Oncology. 119(3):512~518 (4.817)

2016 SCI Significance of histologic tumor grade in rectal cancer treated with preoperative chemoradiotherapy followed by curative surgery: A multi-institutional retrospective study:Radiotherapy and Oncology. 118:387~392 (4.817)

2015 SCI-E What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients After Preoperative Chemoradiotherapy?:Cancer Research and Treatment. 48(3):998~1009 (3.318)

2015 SCI-E Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer.:Cancer Research and Treatment. 48(2):567~573 (3.318)

2015 SCI Risk factors for permanent stoma after rectal cancer surgery with temporary ileostomy:Surgery. 159(3):721~727 (3.38)

2015 SCI-E Robotic Versus Laparoscopic Surgery for Rectal Cancer after Preoperative Chemoradiotherapy: Case-Matched Study of Short-term Outcomes:Cancer research and treatment. 48(1):225~231 (3.318)

2015 SCI Development of a novel proton dosimetry system using an array of fiber-optic Cerenkov radiation sensors:Radiotherapy and Oncology. 117(3):501~504 (4.363)

2015 SCI Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma:Strahlentherapie und Onkologie. 191(11):835~844 (2.914)

2015 SCI Normal Liver Sparing by Proton Beam Therapy for Hepatocellular Carcinoma: Comparison with Helical Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy:Acta oncologica. 54(10):1827~1832 (2.997)

2015 SCI Nomogram prediction of survival in patients with brain metastases from hepatocellular carcinoma treated with wholebrain radiotherapy: a multicenter retrospective study:Journal of Neuro-oncology. 125(2):377~383 (3.07)

2015 SCI Carcinoembryonic antigen has prognostic value for tumor downstaging and recurrence in rectal cancer after preoperative chemoradiotherapy and curative surgery: A multi-institutional and case-matched control study of KROG 14-12.:Radiotherapy and Oncology. 116:202~208 (4.363)

2015 SCI Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer:International Journal of Radiation Oncology Biology Physics. 92:540~547 (4.258)

2015 SCI Can Chemoradiation Allow for Omission of Lateral Pelvic Node Dissection for Locally Advanced Rectal Cancer?:Journal of surgical oncology. 111(4):459~464 (3.244)

2015 SCI-E Robotic Versus Laparoscopic Surgery for Rectal Cancer after Preoperative Chemoradiotherapy: Case-Matched Study of Short-term Outcomes:Cancer research and treatment. 48:225~231 ()

2015 SCI Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: preliminary results of a phase II trial and propensity score analysis.:The Journal of clinical endocrinology and metabolism. 100(3):1009~1017 (6.209)

2015 SCI The Role of Fibrinogen as a Predictor in Preoperative Chemoradiation for Rectal Cancer:Annals of surgical oncology. 22(1):209~215 (3.93)

2015 SCI-E Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma.:Cancer research and treatment. 47(1):34~45 (3.318)

2014 SCI Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma:Strahlentherapie und Onkologie. 190(10):882~890 (2.733)

2014 SCI Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: Pooled analysis of KROG 10-01 and 11-02:Radiotherapy and oncology. 113(1):18~23 (4.857)

2014 SCI Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.:Strahlentherapie und Onkologie. 190(9):806~814 (2.733)

2014 SCI-E Carbohydrate antigen 19-9 levels associated with pathological responses to preoperative chemoradiotherapy in rectal cancer.:Asian Pacific Journal of Cancer Prevention. 15(13):5383~5387 (1.5)

2014 SCI-E Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients:Journal of digestive diseases. 15(7):367~376 (1.924)

2014 SCI-E Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial:The lancet oncology. 15(7):767~774 (24.725)

2014 SCI-E Clinical outcomes of local excision following preoperative chemoradiotherapy for locally advanced rectal cancer:Cancer research and treatment : official journal of Korean Cancer Association. 46(2):158~164 (2.975)

2014 SCI Low-mass-ion discriminant equation: A new concept for colorectal cancer screening.:International Journal of Cancer. 134(8):1844~1853 (5.007)

2014 SCI Serpin B5 is a CEA-interacting biomarker for colorectal cancer.:International Journal of Cancer. 134(7):1595~1604 (5.007)

2014 SCI Prognostic impact of circumferential resection margin in rectal cancer treated with preoperative chemoradiotherapy:Annals of surgical oncology. 21(4):1345~1351 (3.943)

2014 SCI-E Expression of phosphoenolpyruvate carboxykinase linked to chemoradiation susceptibility of human colon cancer cells:BMC Cancer. 14:160~160 (3.319)

2014 SCI-E Influence of family history on survival in patients with colon and rectal cancer:Journal of digestive diseases. 15(3):108~115 (1.924)

2014 SCI Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: A phase II multi-institutional clinical trial (KROG 11-02).:Radiotherapy and Oncology. 110(1):150~154 (4.857)

2013 SCI-E Voxel-based dual time 18F-FDG parametric imaging for rectal cancer: Differentiation of residual tumor from post-chemoradiotherapy changes:Nuclear Medicine Communications. 34(12):1166~1173 (1.379)

2013 SCI-E Dipeptidyl peptidase 10, a novel prognostic marker in colorectal cancer:Yonsei Medical Journal. 54(6):1362~1369 (1.306)

2013 SCI-E Clinical validity of tissue CEA expression as ancillary to serum CEA concentration in patients curatively resected for colorectal cancer.:Colorectal Disease. 15(9):e503~e511 (2.081)

2013 SCI Preoperative Plasma Hyperfibrinogenemia is Predictive of Poor Prognosis in Patients with Nonmetastatic Colon Cancer:Annals of surgical oncology. 20(9):2908~2913 (4.12)

2013 SCI-E Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy:International Journal of Colorectal Disease. 28(9):1217~1224 (2.238)

2013 SCI-E Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer:Colorectal disease. 15(9):e503~e511 (2.081)

2013 SCI Phase II trial of proton beam accelerated partial breast irradiation in breast cancer:Radiotherapy and Oncology. 108(2):209~214 (4.52)

2013 SCI-E Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer:Radiation Oncology. 8(1):160~160 (2.107)

2013 SCI-E Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy:Radiation Oncology. 8:114~114 (2.107)

2013 SCI Preoperative short-course concurrent chemoradiation therapy followed by delayed surgery for locally advanced rectal cancer: a phase 2 multicenter study (KROG 10-01):International Journal of Radiation Oncology, Biology, Physics. 86(1):34~39 (4.524)

2013 SCI-E Association between CASR polymorphisms, calcium intake, and colorectal cancer risk:PLoS One. 8:e59628~e59628 (3.73)

2013 SCI Laparoscopic versus open surgery in stage I rectal cancer: Long-term oncologic outcomes:World Journal of Surgery. 37(3):646~651 (2.228)

2013 SCI Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy:Tumori. 99(1):93~99 (0.922)

2013 SCI Curative radiotherapy using different radiation techniques for isolated lung metastasis from colorectal cancer:Tumori. 99(1):68~75 (0.922)

2013 SCI Combined Primary Tumor and Extracranial Metastasis Status as Constituent Factor of Prognostic Indices for Predicting the Overall Survival in Patients with Brain Metastases:Journal of Korean medical science. 28(2):205~212 (1.249)

2013 SCI-E A prospective observational study with dose volume parameters predicting rectosigmoidoscopic findings and late rectosigmoid bleeding in patients with uterine cervical cancer treated by definitive radiotherapy:Radiation Oncology. 8:28~28 (2.107)

2013 SCI KRAS Mutation Status and Clinical Outcome of Preoperative Chemoradiation With Cetuximab in Locally Advanced Rectal Cancer: A Pooled Analysis of 2 Phase II Trials.:International Journal of Radiation Oncology Biology Physics. 85(1):201~207 (4.524)

2013 SCI-E New Application of Dual Point 18F-FDG PET/CT in the Evaluation of Neoadjuvant Chemoradiation Response of Locally Advanced Rectal Cancer:Clinical nuclear medicine. 38(1):7~12 (2.955)

2012 SCI-E Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009:Cancer Research and Treatment. 44(4):219~226 (0)

2012 SCI-E Up-regulated expression of l-caldesmon associated with malignancy of colorectal cancer:BMC Cancer. 12(1):601~601 (3.011)

2012 SCI Phase 3 Trial of Postoperative Chemotherapy Alone Versus Chemoradiation Therapy in Stage III-IV Gastric Cancer Treated With R0 Gastrectomy and D2 Lymph Node Dissection.:International journal of radiation oncology, biology, physics.. 84:e585~e592 (4.105)

2012 SCI Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01).:Int J Radiat Oncol Biol Phys. 84:955~961 (4.105)

2012 SCI Can the new American Joint Committee on Cancer staging system predict survival in rectal cancer patients treated with curative surgery following preoperative chemoradiotherapy?:Cancer. 118:4961~4968 (4.771)

2012 SCI Monte Carlo Modeling and Validation of a Proton Treatment Nozzle by Using the Geant4 Toolkit:Journal of the Korean Physics Society. 61:1125~1130 (0.447)

2012 SCI Feasibility study of glass dosimeter for In Vivo Measurement: Dosimetric characterization and clinical application in proton beams:International Journal of Radiation Oncology, Biology, Physics. 84(2):e251~e256 (4.105)

2012 SCI The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery:Annals of Oncology. 23(10):2731~2737 (6.425)

2012 기타 An Update on Preoperative Radiotherapy for Locally Advanced Rectal Cancer:J Korean Soc Coloproctol. 28:179~187 (0)

2012 SCI-E Lymph Node Ratio is an Independent Prognostic Factor in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy and Curative Resection.:European Journal of Surgical Oncology. 38(6):478~483 (2.499)

2012 SCI Hydroxymethylglutaryl-Coenzyme A Synthase 2 Expression Is Associated With Chemoradiotherapy Responses in Colorectal Cancer:Diseases of the Colon & Rectum. 55(6):686~694 (3.132)

2012 SCI Reply to Letter: 'What Does Residual Nodal Positivity in Patients With Rectal Cancer Downstaged to ypT0 After Chemoradiotherapy Really Mean?'.:Annals of surgery. 255(5):e2~e2 (7.492)

2012 SCI-E Clinical outcomes of palliative self-expanding metallic stents in patients with malignant colorectal obstruction:Journal of Digestive Diseases. 13(5):258~266 (1.589)

2012 SCI No correlation between pretreatment serum CEA levels and tumor volume in locally advanced rectal cancer patients:Clinica Chimica Acta. 413(3-4):511~515 (2.535)

2012 SCI Tumor Volume Reduction Rate After Preoperative Chemoradiotherapy as a Prognostic Factor in Locally Advanced Rectal Cancer.:International journal of radiation oncology, biology, physics.. 82(2):e193~e199 (4.105)

2012 SCI Stage-to-stage Comparison of Pre-operative and Post-operative Chemoradiotherapy for T3 Mid or Distal Rectal Cancer:Int. J. Radiation Oncology Biol. Phys.. 82(2):856~862 (4.105)

2011 SCI CA 19-9 Level as Indicator of Early Distant Metastasis and Therapeutic Selection in Resected Pancreatic Cancer:International Journal of Radiation Oncology, Biology, Physics. 81:743~748 (4.503)

2011 SCI Role of Adjuvant Chemoradiotherapy for Resected Extrahepatic Biliary Tract Cancer.:International journal of radiation oncology, biology, physics.. 81:853~859 (4.503)

2011 SCI The Effect of a Contrast Agent on Proton Beam Range in Radiotherapy Planning Using Computed Tomography for Patients With Locoregionally Advanced Lung Cancer.:International journal of radiation oncology, biology, physics.. 81:317~324 (4.503)

2011 SCI Pretreatment Carbohydrate Antigen 19-9 Level Indicates Tumor Response, Early Distant Metastasis, Overall Survival, and Therapeutic Selection in Localized and Unresectable Pancreatic Cancer.:International journal of radiation oncology, biology, physics.. 81:623~630 (4.503)

2011 SCI Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter phase II study:International journal of radiation oncology, biology, physics. 81:677~683 (4.503)

2011 SCI Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy?:Histopathology. 59:650~659 (3.569)

2011 SCI Prognostic Significance of Distribution of Lymph Node Metastasis in Advanced Mid or Low Rectal Cancer:Journal of surgical oncology.. 104(5):486~492 (2.428)

2011 SCI Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapy:Journal of Neurooncology. 104(3):745~753 (2.929)

2011 SCI Is the N1c category of the new american joint committee on cancer staging system applicable to patients with rectal cancer who receive preoperative chemoradiotherapy?:Cancer. 117(17):3917~3924 (5.131)

2011 SCI-E Clinical Outcomes of Chemoradiotherapy for Locally Recurrent Rectal Cancer.:Radiation Oncology. 6:51~51 (2.409)

2011 SCI-E Prediction of output factor, range, and spread-out Bragg peak for proton therapy.:Medical Dosimetry. 36(2):145~152 (0.941)

2011 SCI Preoperative Chemoradiation With Irinotecan and Capecitabine in Patients With Locally Advanced Resectable Rectal Cancer: Long-Term Results of a Phase II Study:International Journal of Radiation Oncology Biology Phyics. 79(4):1171~1178 (4.503)

2010 SCI The role of omental flap transposition in patients with locoregional recurrent rectal cancer treated with reirradiation.:Journal of surgical oncology. 102:789~795 (2.502)

2010 SCI The role of omental flap transposition in patients with locoregional recurrent rectal cancer treated with reirradiation.:Journal of surgical oncology. 102:789~795 (2.502)

2010 SCI Pathologic Complete Response of Primary Tumor Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-term Outcomes and Prognostic Significance of Pathologic Nodal Status (KROG 09-01).:Annals of Surgery. 252:998~1004 (7.9)

2010 SCI Curative chemoradiotherapy for isolated retroperitoneal lymph node recurrence of colorectal cancer.:Radiotherapy and oncology. 97:307~311 (4.343)

2010 SCI Absence of hMLH1 or hMSH2 Expression as a Stage-Dependent Prognostic Factor in Sporadic Colorectal Cancers.:ANNALS OF SURGICAL ONCOLOGY. 16(4):356~361 (4.13)

2010 SCI-E Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver metastases and advanced hepatic dysfunction:Radiation Oncology. 5:97~97 (2.529)

2010 SCI Tumor Volume Reduction Rate Measured by Magnetic Resonance Volumetry Correlated with Pathologic Tumor Response of Preoperative Chemoradiotherapy for Rectal Cancer.:International Journal of Radiation Oncology Biology Physics. 78(1):164~171 (4.592)

2010 SCI Early Intrapulmonary Recurrence After Pulmonary Metastasectomy Related to Colorectal Cancer:Annals of Thoracic Surgery. 90:398~405 (3.644)

2010 SCI-E Local Excision Following Preoperative Chemoradiotherapy-induced Downstaging for Selected cT3 Distal Rectal Cancer.:Japanese Journal of Clinical Oncology. 40:754~760 (1.498)

2010 SCI Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancers.:Annals of Surgery. 252(2):336~340 (7.9)

2010 SCI Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer.:Journal of Surgical Oncology. 102:94~99 (2.502)

2010 SCI-E Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial:Lancet oncology. 11(7):637~645 (14.47)

2009 SCI Pathologic Nodal Classification Is the Most Discriminating Prognostic Factor for Disease-Free Survival in Rectal Cancer Patients Treated with Preoperative Chemoradiotherapy and Curative Resection:international journal of radiation oncology biology physics. 77(4):1158~1165 (4.592)

2009 SCI Prognostic impact of peritonealisation in rectal cancer treated with preoperative chemoradiotherapy: Extraperitoneal versus intraperitoneal rectal cancer.:Radiotherapy and Oncology. 94(3):353~358 (4.343)

2009 SCI Resected Colorectal Liver Metastases:Does the Survival Differ According to Postoperative Chemotherapy Regimen?:Journal of Surgical Oncology. 100:713~718 (2.478)

2009 SCI-E Influence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancer:International Journal of Colorectal Disease. 24:1451~1458 (1.767)

2009 SCI Microscopic Gold Particle-based Fiducial Makers for Proton Therapy of Prostate Cancer:International Journal of Radiation Oncology Biology Physics. 74(5):1609~1616 (4.639)

2009 SCI-E Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer.:BMC Cancer. Online:Published (3.087)

2009 SCI Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery:International Journal of Radiation Oncology Biology Physics. 74:810~817 (4.639)

2009 SCI-E Radiation pneumonitis after adjuvant radiotherapy for breast cancer: a volumetric analysis using CT simulator:Journal of Breast Cancer. 12(2):73~78 (0)

2009 SCI Secondary Neutron Doses for Several Beam Configurations for Proton Therapy:International Journal of Radiation Oncology Biology Physics. 74(1):260~265 (4.639)

2008 SCI A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer:Investigational New Drugs. Online:Published (2.806)

2008 SCI Influence of lipiodol agent on proton beam range in radiotherapy planning using computed tomography for hepatocellular carcinoma:International Journal of Radiation Oncology Biology Physics. 72:687~694 (4.29)

2008 SCI Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers:Annals of Surgery. 248:243~251 (7.446)

2008 SCI Computerized tomography-based quality assurance tool for proton range compensators:Medical Physics. 35:3511~3517 (3.198)

2008 기타 Proton Beam Therapy:Journal of Korean Medical Association. 51:638~642 ()

2008 SCI Inter- and intrafractional movement-induced dose reduction of prostate target volume in proton beam treatment:International Journal of Radiation Oncology, Biology, Physics. 71:1091~1102 (4.29)

2008 SCI-E Synchronous penile metastasis from a rectal carcinoma:International Journal of Colorectal Disease. 23:333~334 (1.918)

2008 SCI Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection:Annals of Surgical Oncology. 15:729~737 (3.917)

2008 SCI SMART (Simultaneous Modulated Accelerated RadioTherapy) for locally advanced nasopharyngeal carcinomas.:Head & Neck. 30:159~169 (2.007)

2007 SCI-E Optimal matching of 3D film-measured and planned doses for intensity-modulated radiation therapy quality assurance:Medical Dosimetry. 32:316~324 (0)

2007 SCI Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer:International journal of radiation oncology, biology, physics. 69:1167~1172 (4.463)

2007 SCI Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.:Diseases of the Colon & Rectum. 50:1342~1353 (2.442)

2007 SCI Histopathologic risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type:Journal of Clinical Pathology. 60:912~915 (2.245)

2007 SCI Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy:International Journal of Radiation Oncology Biology Physics. 68:1446~1454 (4.463)

2007 SCI-E Optimized matching of film dosimetry with calculated doses for IMRT quality assurance:Physica Medica. 23:49~57 (0.313)

2007 SCI-E A new homogeneity index based on statistical analysis of the dose-volume histogram:Journal of Applied Clinical Medical Physics. 8:9~17 ()

2007 SCI Intensity-modulated radiotherapy with a belly board for rectal cancer:International Journal of Colorectal Disease. 22:373~379 (2.006)

2007 SCI Endoscopic treatment of completely occluding anastomotic web using incision and ballooning after dye injection:Endoscopy. 39:E102~103 (3.605)

2007 SCI Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer:International Journal of Radiation Oncology Biology Physics. 67:378~384 (4.463)

2007 SCI Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy:International Journal of Radiation Oncology Biology Physics. 67:225~231 (4.556)

2006 SCI Three-dimensional conformal radiotherapy for unresectable hepatocellular carcinoma patients who were Ineffective to or unsuitable for transcatheter arterial chemoembolization.:American journal of clinical oncology. 29:568~575 (1.615)

2006 SCI Three-Dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable:American Journal of Clinical Oncology. 29:568~575 (1.615)

2006 SCI-E Analysis of microsatellite instability in stool DNA of patients with colorectal cancer using denaturing high performance liquid chromatography:World Journal of Gastroenterology. 12(41):6689~6692 ()

2006 SCI Preoperative chemoradiotherapy with concomitant small field boost irradiation for locally advanced rectal cancer: a multi-institutional phase II study (KROG 04-01):Diseases of the Colon & Rectum. 49:1684~1691 (2.264)

2006 SCI Geometric Shifting of Porta Hepatis during posthepatectomy radiotherapy for biliary tract cancer:international journal of radiation oncology biology physics. 66:212~216 (4.556)

2006 SCI The effect of belly board location in rectal cancer patients treated with preoperative radiotherapy:Clinical Oncology. 18:441~446 (1.288)

2006 SCI A new evaluation method of target volume coverage and homogeneity for IMRT treatment planning:Physica Medica. 22:43~51 (0.169)

2006 SCI Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer?:Cancer. 106:1694~1700 (4.8)

2006 SCI Preoperative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge.:EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. 32:162~167 (1.882)

2006 SCI CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.:International Journal of Radiation Oncology Biology Physics. 64(1):197~204 (4.556)

2005 SCI Comparative Analysis of the effects of belly board and bladder distension in postoperative radiotherapy of rectal cancer patients:Strahlentherapie und Onkologie. 181(9):601~605 (3.121)

2005 SCI Dose-volumetric Parameters of Acute Esophageal Toxicity in Patients with Lung Cancer Treated with Three Dimensional Radiotherapy:International Journal of Radiation Oncology Biology Physics. 62:995~1002 (4.297)

2005 SCI A Predictive Marker for Therapeutic Response to Preoperative Chemoradiotherapy in Rectal Carcinoma Patients.:HUMAN PATHOLOGY. 36:364~371 ()

2005 SCI Dose-volumetric Parameters for Predicting Severe Radiation Pneumonitis after Three-dimensional Conformal Radiation Therapy for Lung cancer:Radiology. 235(1):208~224 (5.076)

2005 SCI Dose-volumetric Parameters for Predicting Severe Radiation Pneumonitis after Three-dimensional Conformal Radiation Therapy for Lung cancer:Radiology. 235:208~223 (4.815)

2005 SCI 3-Dimensional Conformal Radiotherapy for Portal Vein Thrombosis of Hepatocellular Carcinoma.:CANCER. 103:2419~2426 (4.434)

2005 SCI Usefulness of MR Volumetric Evaluation in Predicting Response to Preoperative Concurrent Chemoradiotherapy in Patients with Resectable Rectal Cancer.:INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 62:761~768 ()

2005 SCI Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients:Int J Rad Oncol Biol Phy. 0:1918~1924 (4.285)

2004 SCI Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma:Human Pathology. 36(4):364~371 (3.685)

2004 SCI Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view.:BRITISH JOURNAL OF CANCER. 91:11~17 ()

2004 SCI-E Granular cell tumor of colon: Report of a case and review of literature.:WORLD JOURNAL OF GASTROENTEROLOGY. 10:2452~2454 ()

2004 SCI-E Granular cell tumor of colon: report a case and review of literature:World Journal of Gastroenterology. 10:2452~2454 ()

2003 Other A case of primary leiomyosarcoma of the inferior vena cava treated by surgical resection and reconstruction with synthetic graft replacement:Korean Journal of Gastroenterology. 42:249~254 ()

2003 SCI Postoperative chemoradiotherapy for gastric cancer:ANNALS OF ONCOLOGY. 14:1373~1377 ()

2002 SCI Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.:JOURNAL OF KOREAN MEDICAL SCIENCE. 17:537~543 ()

2001 SCI CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?:ANNALS OF ONCOLOGY. 12:349~352 ()

2001 SCI Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer.:ACTA ONCOLOGICA. 40:588~592 ()

2000 SCI Fractionated Stereotactic Radiation Therapy for Exracranial Head and Neck Tumors.:INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 48:501~505 ()

2000 SCI Prompt Radiation Oncology Record Access by Patient Centered Digital Image Chart System at Samsung Medical Center.:RADIOTHERAPY AND ONCOLOGY. 56:117~120 ()

2000 SCI An integrated service digital network (ISDN)-based international telecommunication between Samsung Medical Center and Hokkaido University using telecommunication helped radiotherapy planning and information system (THERAPIS).:RADIOTHERAPY AND ONCOLOGY. 56:121~123 ()

2000 SCI Physical Properties of New Collimator Cone System for Stereotactic Radiation Therapy Developed in Samsung Medical Center.:INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 48:541~544 ()

2000 SCI A Glass Compensator Filter to Improve Breast Image Quality in Radiation Therapy Simulation.:INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 46:1061~1064 ()

LIST